Title : Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.

Pub. Date : 2015 Jul

PMID : 25943175






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance. Phenytoin cytochrome P450 family 2 subfamily C member 9 Homo sapiens
2 CYP2C9 genotype based phenytoin therapy is highly relevant in Kashmiri population due to a high incidence of genetic variations associated with therapeutic and adverse responses to phenytoin. Phenytoin cytochrome P450 family 2 subfamily C member 9 Homo sapiens
3 CYP2C9 genotype based phenytoin therapy is highly relevant in Kashmiri population due to a high incidence of genetic variations associated with therapeutic and adverse responses to phenytoin. Phenytoin cytochrome P450 family 2 subfamily C member 9 Homo sapiens